Skip to main content

Table 1 Summary of clinical complaint at presentation and treatments

From: Changes over time in craniocerebral morphology and syringomyelia in cavalier King Charles spaniels with Chiari-like malformation

Case Details

First Scan

Scan interval (months)

Second Scan

Change in SM lesion width (mm)

No.

Age (months)/sex

Clinical complaint

Treatment

Clinical complaint2

Treatment

1

78/female neutered

Cervical hyperaesthesia Ataxia

Carprofen

42

Poor control of original complaint

Prednisolone

0

2

59/male neutered

Dysaesthetic behaviour1

Gabapentin

5

Poor control of original complaint

Gabepentin

1.4

3

13/male neutered

Dysaesthetic behaviour1

Gabapentin

17

Poor control of original complaint

Prednisolone

0

4

74/male neutered

Cervical hyperaesthesia

Gabapentin

3

Dysaesthetic behaviour1

Pregabalin

0.1

5

6/female

Dysaesthetic behaviour1 Ataxia

Meloxicam Gabapentin

83

Recurrent generalised seizures

Phenobarbitone Gabapentin Meloxicam

3.5

6

51/male neutered

Cervical hyperaesthesia

Acetazolamide Meloxicam

6

Poor control of original complaint

Acetazolamide Gabapentin

0.3

7

15/male

Seizures

Phenobarbitone

20

Recurrent generalised seizures

Phenobarbitone Levetiracetam

2.2

8

67/male neutered

Cervical hyperaesthesia Head tilt Ataxia

Clindamycin

4

Complex partial seizures

Phenobarbitone

0

9

24/female

Cervical hyperaesthesia

None

11

Recurrent generalised seizures

Potassium Bromide

2.7

10

6/male

Cervical hyperaesthesia

Carprofen

37

Migrating foreign body

Carprofen Prednisolone Trimethoprin-sulphonamide

1.4

11

90/male neutered

Facial paresis

Potentiated amoxcillin Meloxicam

3

Head tilt

Enrofloxacin

0.4

12

48/female neutered

Cervical hyperaesthesia

Gabapentin

8

Complex partial seizures

Potassium Bromide

0

  1. Dysaesthetic behaviour included phantom scratching and facial rubbing.
  2. Clinical complaints considered not attributable to CM/SM included seizures, head tilt, facial paresis and migrating foreign bodies.